(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.52%) $78.89
(-1.18%) $2.17
(0.27%) $2 337.40
(0.26%) $27.69
(0.56%) $970.30
(-0.01%) $0.928
(-0.05%) $10.82
(-0.03%) $0.796
(-0.02%) $91.33
Live Chart Being Loaded With Signals
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic...
Stats | |
---|---|
本日の出来高 | 29.18M |
平均出来高 | 35.54M |
時価総額 | 67 301.93B |
EPS | IDR0 ( 2024-04-28 ) |
次の収益日 | ( IDR18.16 ) 2024-08-02 |
Last Dividend | IDR0 ( N/A ) |
Next Dividend | IDR0 ( N/A ) |
P/E | 23.42 |
ATR14 | IDR4.26 (0.29%) |
ボリューム 相関
PT Kalbe Farma Tbk. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
PT Kalbe Farma Tbk. 相関 - 通貨/商品
PT Kalbe Farma Tbk. 財務諸表
Annual | 2023 |
収益: | IDR30 449.13B |
総利益: | IDR11 438.05B (37.56 %) |
EPS: | IDR59.81 |
FY | 2023 |
収益: | IDR30 449.13B |
総利益: | IDR11 438.05B (37.56 %) |
EPS: | IDR59.81 |
FY | 2022 |
収益: | IDR28 933.50B |
総利益: | IDR11 704.07B (40.45 %) |
EPS: | IDR72.71 |
FY | 2021 |
収益: | IDR26 261.19B |
総利益: | IDR11 283.78B (42.97 %) |
EPS: | IDR67.92 |
Financial Reports:
No articles found.
PT Kalbe Farma Tbk.
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. The company also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, it offers contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products, as well as operates Mitrasana Clinics, a health care service. Further, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。